GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai InnoStar Bio-tech Co Ltd (SHSE:688710) » Definitions » Scaled Net Operating Assets

Shanghai InnoStar Bio-tech Co (SHSE:688710) Scaled Net Operating Assets : 0.43 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai InnoStar Bio-tech Co's operating assets for the quarter that ended in Sep. 2024 was ¥1,779 Mil. Shanghai InnoStar Bio-tech Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥631 Mil. Shanghai InnoStar Bio-tech Co's Total Assets for the quarter that ended in Jun. 2024 was ¥2,645 Mil. Therefore, Shanghai InnoStar Bio-tech Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.43.

Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets Historical Data

The historical data trend for Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets Chart

Shanghai InnoStar Bio-tech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
0.05 0.28 0.48 0.24 0.28

Shanghai InnoStar Bio-tech Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.43

Competitive Comparison of Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets

For the Drug Manufacturers - General subindustry, Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets falls into.


;
;

Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(1617.215-889.453)/2618.267
=0.28

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2775.441 - 1158.226
=1617.215

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1135.954 - 215.103 - 31.398
=889.453

Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(1779.365-631.493)/2644.962
=0.43

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3263.196 - 1483.831
=1779.365

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=878.026 - 210.136 - 36.397
=631.493

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai InnoStar Bio-tech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai InnoStar Bio-tech Co Ltd (SHSE:688710) » Definitions » Scaled Net Operating Assets
Comparable Companies
SZSE:000411 SZSE:301507 SHSE:600713 SZSE:301096 SZSE:000908 SZSE:300006 SZSE:002198 SZSE:301281 SHSE:600613 SZSE:001367 LLY JNJ ABBV OCSE:NOVO B XSWX:ROG LSE:AZN MRK XSWX:NOVN AMGN PFE
Traded in Other Exchanges
N/A
Address
No. 199 Guo Shoujing Road, Room 106, Pilot Free Trade Zone, Shanghai, CHN, 201203
Website
https://www.innostar.cn
Shanghai InnoStar Bio-tech Co Ltd is a comprehensive research and development services (CRO) enterprise that specializes in providing biomedical non-clinical research services.

Shanghai InnoStar Bio-tech Co Headlines

No Headlines